ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

The Association of the British Pharmaceutical Industry (ABPI) has appointed Pfizer Europe's former head of head of public affairs and policy Colette Goldrick as its first Northern Ireland director.

A native of Northern Ireland, Goldrick will be tasked with the identification, establishment and development of relationships with key opinion leaders and decision makers in the nation.

“The ABPI believes that Northern Ireland represents a significant opportunity for the bio-pharmaceutical industry in terms of the growing life science agenda, arising from world class capability at Queen's University Belfast, the University of Ulster and the Science Park,” said the ABPI's chief executive Stephen Whitehead.

“Our partnership based approach will seek to engage all stakeholders in supporting healthcare professionals to effectively utilise innovative medicines and improve patient health.”

Goldrick has a strong pedigree within the pharma industry, serving in senior positions in public affairs and communications at both Pfizer and GlaxoSmithKline.

Prior to her most recent role at Pfizer, she was Pfizer UK's head of communications and corporate affairs director. During her time at the pharma giant, she won Communiquétor of the Year at the Communiqué Awards 2008. At GSK, Goldrick served in several roles, rising to head of communications.